Yüklüyor......
Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
AIM: The purpose of this study was to treat burning mouth syndrome (BMS) with a combination of painful gabapentin and ultramicronized palmitoylethanolamide (umPEA), in an attempt to improve the severe symptomatology of BMS. METHODS: We examined the case of a 60-year-old male, suffering from late-ons...
Kaydedildi:
| Yayımlandı: | Int Med Case Rep J |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6385774/ https://ncbi.nlm.nih.gov/pubmed/30858732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IMCRJ.S194403 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|